Events

Participants include CARB-X funded companies Eligo Bioscience and Seres Therapeutics. As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target […]

Jointly organised by the BSAC and GARDP. For 2021, the conference collaborators are the Helmholtz Institute for Pharmaceutical Sciences (HIPS), the German Center for Infection Research (DZIF) and the International Research Alliance for Antibiotic Discovery and Development (IRAADD) (a JPIAMR funded network) Click here to learn more. Click here to register.

India is fast emerging as one of the global hubs for conducting pre- clinical and clinical development. The webinar will showcase the competencies of some of the CROs in India and how Product Developers can leverage the advantages of working with Indian CROs.  Participating CROs include: Bioneeds India Syngene International SIRO Clinpharm Sai Life Sciences […]

The Bloomsbury SET is hosting its first virtual conference focused on knowledge exchange and infectious disease during the 22nd to 26th February 2021. Throughout the week, the Bloomsbury SET and wider partners will explore interdisciplinary innovation, research translation, commercialisation, impact and connecting capabilities to tackle global health challenges through knowledge exchange.  Click here to learn more. Click […]

Join us at the International Phage Futures Congress in 2021, as we create a virtual stage upon which to initiate all-important discussions & forge partnerships between key stakeholders from all over the world. Experts in their respective fields will discuss how to translate new phage-based applications into clinical studies & beyond. Discover how you can […]

Speakers: Patricia Bradford, Antimicrobial Development Specialists LLC (US); Alita Miller, Entasis Therapeutics (US) Moderator: Michael Mourez, École d’Ingénieurs de PURPAN (France) The presentations will be followed by a Q&A session. Click here to learn more and register.

The COVID-19 pandemic has brought into sharp focus the impact of pandemics. The novel coronavirus has claimed more than a million lives, trillions of dollars have been lost, expenditures cut and international efforts to achieve the Sustainable Development Goals put in jeopardy. COVID-19 has demonstrated pandemic preparedness requires a global coordinated effort, and no country […]

Multi-drug resistant (MDR) organisms are a threat to national security and public health. As rates of antimicrobial resistance (AMR) in pathogens continue to increase new therapeutics and vaccines are essential to combat the growing crisis.  Every year, 2.8 million American develop a drug resistant infection and 35,000 people die. Globally, MDR infections kill 700,000 each […]

The 3rd Bacteriophage Therapy Summit returns! With a new looking speaker line-up and never before seen content, we are excited to continue to unite the community to progress fundamental bacteriophage research into clinically-significant products. The overuse of antibiotics had led to the development of multi-resistant bacterial strains, most notably ESKAPE pathogens, rendering the use of […]

The ASID Annual Scientific Meeting is the leading Australasian meeting for adult and paediatric infectious disease and clinical microbiology specialists. The conference is an ideal opportunity for connecting clinicians, microbiologists and other health professions with a common interest in infectious diseases and provides a friendly forum for the exchange of scientific advances in the prevention, […]